Renal Cancer - Results from #2480

Prognostic Role of Prothrombin Time Activity, Prothrombin Time, Albumin/Globulin Ratio, Platelets, Sex, and Fibrinogen in Predicting Recurrence-Free Survival Time of Renal Cancer. September 30, 2020

Comprehensive analysis on the expression levels and prognostic values of LOX family genes in kidney renal clear cell carcinoma. September 30, 2020

Comprehensive geriatric assessment is an independent prognostic factor in older patients with metastatic renal cell cancer treated with first-line Sunitinib or Pazopanib: a single center experience. September 29, 2020

CRISPR/Cas9 genome-wide loss-of-function screening identifies druggable cellular factors involved in sunitinib resistance in renal cell carcinoma. September 29, 2020

Identification of KIF18B as a Hub Candidate Gene in the Metastasis of Clear Cell Renal Cell Carcinoma by Weighted Gene Co-expression Network Analysis. September 29, 2020

Long Non-Coding RNA Profile Study Identifies an Immune-Related lncRNA Prognostic Signature for Kidney Renal Clear Cell Carcinoma. September 28, 2020

Everolimus plus bevacizumab is an effective first-line treatment for patients with advanced papillary variant renal cell carcinoma: Final results from a phase II trial. September 28, 2020

USP22 promotes proliferation in renal cell carcinoma by stabilizing survivin. September 28, 2020

Association of preoperative serum De Ritis ratio with oncological outcomes in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinoma. September 25, 2020

Poststreptococcal acute glomerulonephritis in a girl with renal cell carcinoma: possible pathophysiological association. September 25, 2020

Association of Surgical Delay and Overall Survival in Patients with T2 Renal Masses: Implications for Critical Clinical Decision-Making during the COVID-19 Pandemic. September 25, 2020

Development of novel ACN (albumin, C-reactive protein and neutrophil-to-lymphocyte ratio) prognostication model for patients with metastatic renal cell carcinoma receiving first-line molecular-targeted therapy. September 24, 2020

A Systematic Review and Meta-Analysis of the Significance of Body Mass Index on Kidney Cancer Outcomes. September 24, 2020

Surgical Outcome of Renal Cell Carcinoma with Tumor Thrombus Extension into Inferior Vena Cava and Right Atrium (Beating Heart Removal of Level 4 Thrombus): A Challenging Scenario. September 24, 2020

Surgical Management and Outcomes of Renal Tumors Arising from Horseshoe Kidneys: Results from an International Multicenter Collaboration. September 23, 2020

Black race may be associated with worse overall survival in renal cell carcinoma patients. September 23, 2020

Fear of Cancer Recurrence in Patients With Localized Renal Cell Carcinoma. September 23, 2020

Immune evasion in renal cell carcinoma: biology, clinical translation, future directions. September 22, 2020

Novel Therapeutic Approaches and the Evolution of Drug Development in Advanced Kidney Cancer. September 22, 2020

Androgen receptor modulates metastatic routes of VHL wild-type clear cell renal cell carcinoma in an oxygen-dependent manner. September 22, 2020

Page 125 of 456